American Financial Tribune: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Financial Tribune.

Press releases published on April 17, 2026

Apr. 17, 2026

Theriva™ Biologics Announces Upcoming Presentation of Additional Data from the VIRAGE Phase 2b Clinical Trial of VCN-01 in Metastatic Pancreatic Cancer at AACR 2026 Annual Meeting

Indeterminate GlobeNewswire

Apr. 17, 2026

4DMT Announces New Employment Inducement Grants

Indeterminate GlobeNewswire

Apr. 17, 2026

CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Apr. 17, 2026

Vera Bradley Terminates Existing Shareholder Rights Plan

Indeterminate GlobeNewswire

Apr. 17, 2026

SEALSQ Announces Agenda of its 2026 Annual General Meeting of Shareholders

Indeterminate GlobeNewswire

Apr. 17, 2026

ORIC® Pharmaceuticals Presents Preclinical Data to Support the Potential of Rinzimetostat Across Prostate Cancer and in Emerging Resistance Settings at the 2026 American Association for Cancer Research (AACR) Annual Meeting

Indeterminate GlobeNewswire

Apr. 17, 2026

QuasarEdge Acquisition Corporation Announces Exercise of Over-Allotment Option

Indeterminate GlobeNewswire

Apr. 17, 2026

Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026

Indeterminate GlobeNewswire

Apr. 17, 2026

Talen Energy Announces Pricing of Senior Notes

Indeterminate GlobeNewswire

Apr. 17, 2026

VALUE LINE, INC. DIVIDEND HAS JUST BEEN RAISED FROM $1.30 TO $1.40 (ANNUALIZED) – ITS 12TH CONSECUTIVE INCREASE

Indeterminate GlobeNewswire

Apr. 17, 2026

Revolution Medicines Announces Closing of Concurrent Upsized Public Offerings with Aggregate Gross Proceeds of Approximately $2.2 Billion, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Indeterminate GlobeNewswire

Apr. 17, 2026

Adagene Presents Two Posters at AACR 2026 with New Data Highlighting Muzastotug’s Potential as a Backbone Combination Therapy for Multiple Tumor Types

Indeterminate GlobeNewswire

Apr. 17, 2026

Xilio Therapeutics Announces New Preclinical Data at AACR Annual Meeting for XTX601, a Masked T Cell Engager Targeting CLDN18.2

Indeterminate GlobeNewswire

Apr. 17, 2026

Cardiff Oncology Presents Preclinical Data on its PLK1 Inhibitor Onvansertib in Combination with a HER2-Targeted ADC at the 2026 AACR Annual Meeting

Indeterminate GlobeNewswire

Apr. 17, 2026

Olema Oncology Announces Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting

Indeterminate GlobeNewswire

Apr. 17, 2026

Hingham Savings Reports First Quarter 2026 Results

Indeterminate GlobeNewswire

Apr. 17, 2026

New Era Energy & Digital Announces Appointment of Andy Casazza as Chief Corporate Officer

Indeterminate GlobeNewswire

Apr. 17, 2026

Top Orlando Remodeler Release: How to Read Contractor Reviews Like an Insider And The Red Flags Homeowners Miss

Indeterminate EIN Presswire

Apr. 17, 2026

Acrivon to Highlight Preclinical Data with Three Posters at AACR Demonstrating Strong ACR-368 and ACR-2316 Synergies with Immune Checkpoint Inhibitors and ADC Payloads, Revealing Broad Clinical Development Opportunities

Indeterminate GlobeNewswire

Apr. 17, 2026

Freshpet Inc. (NASDAQ: FRPT) Investigated for Potential Federal Securities Laws Violations – Lowey Dannenberg, P.C.

Indeterminate GlobeNewswire